Cargando…
B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model
AIMS/HYPOTHESIS: Type 1 diabetes is a T cell-mediated autoimmune disease characterised by the destruction of beta cells in the islets of Langerhans, resulting in deficient insulin production. B cell depletion therapy has proved successful in preventing diabetes and restoring euglycaemia in animal mo...
Autores principales: | Da Rosa, Larissa C., Boldison, Joanne, De Leenheer, Evy, Davies, Joanne, Wen, Li, Wong, F. Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449006/ https://www.ncbi.nlm.nih.gov/pubmed/29594371 http://dx.doi.org/10.1007/s00125-018-4597-z |
Ejemplares similares
-
Phenotypically distinct anti-insulin B cells repopulate pancreatic islets after anti-CD20 treatment in NOD mice
por: Boldison, Joanne, et al.
Publicado: (2019) -
Gene expression profiling in NOD mice reveals that B cells are highly educated by the pancreatic environment during autoimmune diabetes
por: Boldison, Joanne, et al.
Publicado: (2022) -
Inotuzumab Ozogamicin Murine Analog–Mediated B-Cell Depletion Reduces Anti-islet Allo- and Autoimmune Responses
por: Carvello, Michele, et al.
Publicado: (2012) -
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
por: Chen, Dawei, et al.
Publicado: (2023) -
Regulatory B Cells: Role in Type 1 Diabetes
por: Boldison, Joanne, et al.
Publicado: (2021)